Advertisement

Topics

Invitae sells $73.5mm of its common and preferred shares through private placement

15:40 EDT 3 Aug 2017 | Elsevier Business Intelligence

Genetic testing firm Invitae Corp. grossed $73.5mm through a private placement of common and preferred shares to new and exis...

Original Article: Invitae sells $73.5mm of its common and preferred shares through private placement

NEXT ARTICLE

More From BioPortfolio on "Invitae sells $73.5mm of its common and preferred shares through private placement"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.